A novel autotransfusion device saving erythrocytes and platelets used in a 72 h survival swine model of surgically induced controlled blood loss.
Kévin SchreiberBenoit DecoutureAudrey LafragetteStéphane CholletMarine BruneauMaxence NicolletCatherine WittmannFrancis GadratAlexandre MansourPatricia Forest-VillegasOlivier GauthierGwenola Touzot-JourdePublished in: PloS one (2022)
In the present study, both animal models succeeded in reproducing clinical conditions of perioperative cardiac and non-cardiac blood loss. Sufficient blood was collected to allow evaluation of autotransfusion effects on animals and to demonstrate the system performance by evaluating its capacity to collect, wash and concentrate red blood cells and platelets. Reinfusion of the treated blood, containing not only concentrated red blood cells but also platelets, did not lead to any postoperative adverse nor thrombogenic events. Clinical and comparative studies need to be conducted to confirm the clinical benefit of platelet reinfusion.